{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:03:27Z","timestamp":1715987007400},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jhep.2013.06.030","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T14:00:54Z","timestamp":1373464854000},"page":"964-971","source":"Crossref","is-referenced-by-count":19,"title":["Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients"],"prefix":"10.1016","volume":"59","author":[{"given":"Thomas-Matthias","family":"Scherzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert Friedrich","family":"St\u00e4ttermayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Stauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Maieron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Laferl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remy","family":"Schwarzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Datz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karoline","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Beinhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Steindl-Munda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ferenci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2013.06.030_b0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2013.06.030_b0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(10)60934-8","article-title":"Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial","volume":"376","author":"Kwo","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2013.06.030_b0015","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa0807650","article-title":"Telaprevir and peginterferon with or without ribavirin for chronic HCV infection","volume":"360","author":"H\u00e9zode","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.06.030_b0020","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/he.2000.5789","article-title":"Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage","volume":"31","author":"De Franceschi","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.06.030_b0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hep.24068","article-title":"Inosinetriphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2\/3 but do not decrease dose reductions of RBV or increase SVR","volume":"53","author":"Thompson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.06.030_b0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00439-002-0798-z","article-title":"Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency","volume":"111","author":"Sumi","year":"2002","journal-title":"Hum Genet"},{"key":"10.1016\/j.jhep.2013.06.030_b0035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s100380200095","article-title":"DNA polymorphisms in ITPA including basis of inosine triphosphatase deficiency","volume":"47","author":"Cao","year":"2002","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jhep.2013.06.030_b0040","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jmb.2009.07.051","article-title":"Functional study of the P32T ITPA variant associated with drug sensitivity in humans","volume":"392","author":"Stepchenkova","year":"2009","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jhep.2013.06.030_b0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbadis.2006.10.006","article-title":"The ITPA c.94C>A and g.IVS2+21A>C sequence variants contribute to missplicing of the ITPA gene","volume":"1772","author":"Arenas","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2013.06.030_b0050","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1053\/j.gastro.2010.12.038","article-title":"Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function","volume":"140","author":"Hitomi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.06.030_b0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature08825","article-title":"ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C","volume":"464","author":"Fellay","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.06.030_b0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/hep.24058","article-title":"Influenceof ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir","volume":"53","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.06.030_b0065","first-page":"974","article-title":"Swiss Hepatitis C Cohort Study Group (SCCS). Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection","volume":"57","author":"Rau","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.06.030_b0070","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2013.06.030_b0075","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.06.030_b0080","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jhep.2012.08.003","article-title":"Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial","volume":"57","author":"Furusyo","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.06.030_b0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2005.09.015","article-title":"Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-na\u00efve patients with chronic hepatitis C genotype 1 infection","volume":"44","author":"Ferenci","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.06.030_b0090","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1053\/j.gastro.2009.10.058","article-title":"Peginterferon alfa-2a\/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virologic response","volume":"138","author":"Ferenci","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.06.030_b0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2008.04.015","article-title":"Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response","volume":"135","author":"Ferenci","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.06.030_b0100","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/hep.25892","article-title":"High SVR rates in RVR patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials","volume":"56","author":"Marcellin","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.06.030_b0105","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.06.030_b0110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/13697137.2010.507886","article-title":"Age of menopause and impact of climacteric symptoms by geographical region","volume":"13","author":"Palacios","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.jhep.2013.06.030_b0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0016-5085(99)70236-2","article-title":"The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C","volume":"116","author":"Kazemi-Shirazi","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.06.030_b0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2893.2011.01522.x","article-title":"Optimal treatment duration for patients with HCV genotype 1 infection","volume":"19","author":"Ferenci","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2013.06.030_b0125","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.26096","article-title":"Anemia during treatment with peginterferon alfa-2b\/ribavirin and boceprevir: analysis from the SPRINT-2 trial","volume":"57","author":"Sulkowski","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.06.030_b0130","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.3748\/wjg.v18.i41.5879","article-title":"Several factors including ITPA polymorphism influence ribavirin-induced anemia in chronic hepatitis C","volume":"41","author":"Tsubota","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.06.030_b0195","series-title":"Worldwide prevalence of anaemia 1993\u20132005: WHO global database on anaemia","author":"Bruno de Benoist","year":"2008"},{"key":"10.1016\/j.jhep.2013.06.030_b0140","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4254\/wjh.v2.i8.302","article-title":"Gender-related variations in iron metabolism and liver diseases","volume":"2","author":"Harrison-Findik","year":"2010","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2013.06.030_b0145","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jhep.2013.06.030_b0150","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJMcibr0906391","article-title":"The microcytic red cell and the anemia of inflammation","volume":"361","author":"Keel","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.06.030_b0155","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","article-title":"Immunoassay for human serum hepcidin","volume":"112","author":"Ganz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.06.030_b0160","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1210\/en.2011-2045","article-title":"17\u03b2-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site","volume":"153","author":"Yang","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2013.06.030_b0165","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.25666","article-title":"Pegylated interferon-\u03b1 induced hypoferremia is associated with the immediate response to treatment in hepatitis C","volume":"56","author":"Ryan","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.06.030_b0170","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1182\/blood-2010-07-294595","article-title":"Why do women have similar erythropoietin levels to men but lower hemoglobin levels?","volume":"116","author":"Murphy","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.06.030_b0175","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1006\/bbrc.1995.2364","article-title":"Oestrogen increases endothelial nitric oxide by a receptor mediated system","volume":"214","author":"Hayashi","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2013.06.030_b0180","first-page":"147","article-title":"\u2018Regulation\u2019 of capillary haematocrit","volume":"3","author":"Gaehtgens","year":"1984","journal-title":"Int J Microcirc Clin Exp"},{"key":"10.1016\/j.jhep.2013.06.030_b0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0035-9203(94)90505-3","article-title":"Parasite density of Plasmodium falciparum malaria in Ghanaian schoolchildren: evidence for influence of sex hormones?","volume":"88","author":"Landgraf","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jhep.2013.06.030_b0190","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1128\/IAI.00008-06","article-title":"Involvement of gonadal steroids and gamma interferon in sex differences in response to blood-stage malaria infection","volume":"74","author":"Cernetich","year":"2006","journal-title":"Infect Immun"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813004480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813004480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T13:50:31Z","timestamp":1539525031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827813004480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0168827813004480"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2013.06.030","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}